Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:50
876.00
-1.45 (-0.17%)
VOLUME 43,126
LIVE
NSE
Oct 19, 19:45
879.85
2.55 (0.29%)
VOLUME 203,741
News on Divis Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Divi's Laboratories; target of Rs 1080: Axis Direct

5.37 pm | 09 Oct 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated ...

These 7 stocks that saw double-digit growth in free cash flow over last 4 fiscals

11.16 am | 05 Oct 2017 |  Source: Moneycontrol.com

Moneycontrol ran an analysis of companies which generated consistently double-digit growth in cash flows in the last four fiscal years....

Divis Laboratories may slip to Rs 750, Gail may test Rs 485-500: Ashwani Gujral 

10.41 am | 29 Sep 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com feels that Divis Laboratories may slip to Rs 750....

Buy Divis Laboratories, Bharat Electronics; sell Oil India: Ashwani Gujral 

1.20 pm | 28 Sep 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one may buy Divis Laboratories and Bharat Electronics....

Sell Divis Lab, HPCL; buy Motilal Oswal Financial: Ashwani Gujral 

11.06 am | 28 Sep 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com is of the view that one may buy Motilal Oswal Financial Services....

Stocks 360: Here's a 360 degree view on Divis Lab 

3.15 pm | 27 Sep 2017 |  Source: CNBC-TV18

Watch CNBC-TV18's Ekta Batra giving a 360 degree round up on Divis Laboratories....

Hold Divis Laboratories, target Rs 1000: Sandeep Wagle 

2.34 pm | 27 Sep 2017 |  Source: CNBC-TV18

Sandeep Wagle of powermywealth.com is of the view that one may hold Divis Laboratories....

Top buzzing midcap stocks to trade on September 27 

12.25 pm | 27 Sep 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Divis Laboratories, Sun Pharmaceutical, Den Networks, an...

Divis Labs tanks 9% after USFDA issues 6 observations to Vizag unit 2 

10.38 am | 27 Sep 2017 |  Source: Moneycontrol.com

After inspecting the plant during September 11-19, the US Food and Drug Administration has issued six observations including failure in testing indivi...

Short Divis Laboratories, buy DHFL: Ashwani Gujral 

10.31 am | 27 Sep 2017 |  Source: CNBC-TV18

Ashwani Gujral of ashwanigujral.com advises shorting Divis Laboratories....

PM Modi says traders positive about GST, just need 'handholding'

7.02 am | 27 Sep 2017 |  Source: Moneycontrol.com

Bringing you the latest news updates on the go....

Hold Divi’s Laboratories; target of Rs 1040: Sharekhan

3.33 pm | 26 Sep 2017 |  Source: Moneycontrol.com

Sharekhan is recommended hold rating on Divi’s Laboratories with a target price of Rs 1040 in its research report dated September 20, 2017....

Divis Labs Chairman's speech

6.53 pm | 25 Sep 2017 |  Source: Moneycontrol.com

Further to our communication dated September 25, 2017, please find attached herewith copy of Chairman's Speech delivered at the 27th Annual Genera...

Divis Labs jumps 5% as Axis Capital upgrades, hikes target sharply post USFDA audit 

11.58 am | 21 Sep 2017 |  Source: Moneycontrol.com

Axis Capital has upgraded the rating on stock to buy and hiked its target price to Rs 1,080 from Rs 625 per share, following increase in earnings esti...

Dimensions' Srivastava says pharma rally likely to be short lived; likes consumption space 

10.03 am | 21 Sep 2017 |  Source: CNBC-TV18

Rupee movement and price control, among others, could keep a check on pharma. He feels PSU banks could be an arbitrage play....

Stocks 360: Here's a 360 degree view on Divis Lab & Dr Reddys 

3.32 pm | 20 Sep 2017 |  Source: CNBC-TV18

Watch CNBC-TV18’s Ekta Batra give a 360 degree round up on Divis Laboratories and Dr Reddys Laboratories....

Divis Laboratories soars 6% after unit 2 receives Form 483 with six observations 

10.52 am | 20 Sep 2017 |  Source: Moneycontrol.com

Divi's has received a Form 483 citing six observations which are procedural, but all previous observations have been confirmed as completed and re...

Divis Labs: Updates on USFDA inspection

10.51 am | 20 Sep 2017 |  Source: Moneycontrol.com

We wish to inform that Divi's Laboratories, Unit-2 has been inspected by US-FDA from September 11 to September 19, 2017. On completion of this ins...

Still a stock-specific market; cautious on housing finance cos: Experts 

4.46 pm | 19 Sep 2017 |  Source: CNBC-TV18

Independent market expert Ambareesh Baliga says this is a traders market and so it is better to take your profits on a daily basis....

Earnings will see some impact if Divi's Unit 2 does not get cleared by USFDA: Analyst 

10.03 am | 19 Sep 2017 |  Source: CNBC-TV18

The ongoing re-inspection at Unit 2 of Divi's Laboratories remains in focus. In an interview to CNBC-TV18, Amey Chalke of HDFC Securities shared h...

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.